Showing 301-310 of 353 grants

Title Institution Researcher Program Duration Total Award Amount
Nano-encapsulated microparticulate drug delivery platforms for decreasing islet graft immunogenicity University of Miami Dhanashree Surve Cures 01-March-2026 to 28-February-2029 $274,010.00
Localized delivery of costimulatory inhibitors and tolerogenic stromal cells for targeted immunomodulation in beta cell replacement University of Miami Alice Tomei Cures 01-February-2024 to 31-January-2027 $824,892.00
Insulin dose and vascular complications in T1D: its role beyond insulin resistance and glycemia University of Pittsburgh Rachel Miller Improving Lives 01-July-2026 to 30-June-2029 $749,947.12
New approach for tolerance induction after allogeneic islets transplantation University of Pittsburgh Eric Lagasse Cures 01-September-2026 to 31-August-2027 $249,994.05
Dock2-mediated T cell migration as a targetable shared mechanism in autoimmunity University of Pittsburgh Alok Joglekar Cures 01-September-2025 to 28-February-2027 $149,999.05
Engineered Regulatory T cells for Suppression of Type 1 Diabetes University of Pittsburgh Alok Joglekar Cures 01-August-2026 to 31-July-2028 $187,584.10
Can Addition of Pioglitazone to SGLT2 Inhibitor in Type 1 Diabetic Patients Amplify the Decrease in HbA1c and Mitigate Diabetic Ketoacidosis Risk? University of Texas Health Science Center at San Antonio Muhammad Abdul-Ghani Improving Lives 01-June-2019 to 31-December-2026 $1,573,835.31
Optimization of fast-acting venom insulins as therapeutic candidates for T1D University of Utah Helena Safavi Improving Lives 01-September-2022 to 31-August-2026 $890,372.53
Structural approaches to understand biased insulin signaling and design glucose-binding proteins for smart insulin therapeutics University of Utah Amber Vogel Improving Lives 01-March-2024 to 28-February-2027 $228,995.00
microRNAs as regulators of stem cell differentiation into islet cells University of Washington Vincenzino Cirulli Cures 01-August-2025 to 31-July-2027 $600,000.00